John M. Vierling

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial”.

Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trial

Nature Medicine(2023)10.1038/s41591-022-02200-8

N/A

3.0DataRank · unranked

167 citations

Patricia López, Eric Lawitz, Kathryn Jean Lucas, Juergen Loeffler, Won Kim +22 more

Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report

Journal of Hepatology(2023)10.1016/j.jhep.2023.04.033

N/A

0DataRank · unranked

152 citations

Guruprasad P. Aithal, Ynto S. de Boer, Rodrigo Liberal, Alexander L. Gerbes, Arie Regev +29 more

Metabolomics biomarkers of hepatocellular carcinoma in a prospective cohort of patients with cirrhosis

JHEP Reports(2024)10.1016/j.jhepr.2024.101119

N/A

0DataRank · unranked

19 citations

Antoine C. Fontillas, Suet‐Ying Kwan, Caren I. Sanchez, Tiffany L. Calderone, J. Lee +7 more